Deprescribing Hypnotics

Deprescribing Hypnotics is a clinical pharmacotherapy strategy that systematically identifies and reduces or discontinues the use of hypnotic medications in patients when their long-term risks outweigh therapeutic benefits, with the aim of minimizing dependency, adverse effects, and iatrogenic harm while maintaining sleep quality and overall well-being.

17

Publications

680

Citations

63

Authors

37

Institutions

Publications per year

2017–2026

7

Authors

63

  1. CT
    Cara Tannenbaum

    Université de Montréal, Canada

    3 publications · 88 citations

    3

    h-index

  2. JP
    Justin P. Turner

    Université de Montréal, Canada

    2 publications · 49 citations

    2

    h-index

  3. TC
    Todd C. Lee

    McGill University Health Centre, Canada

    1 publications · 39 citations

    1

    h-index

  4. ZB
    Zachary Bouck

    University of Toronto, Canada

    1 publications · 32 citations

    1

    h-index

  5. CC
    Catherine Coveney

    University of Warwick, United Kingdom

    1 publications · 41 citations

    1

    h-index

1–5 of 63

Venues

  1. PubMed

    Repository · 1 publications · 10 citations

    1

    h-index

  2. BMJ Open

    1 publications · 37 citations

    1

    h-index

  3. American Journal of Psychiatry

    1 publications · 131 citations

    1

    h-index

  4. The Permanente Journal

    1 publications · 43 citations

    1

    h-index

  5. Research Square

    Repository · 1 publications · 15 citations

    1

    h-index

1–5